BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 35773121)

  • 1. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.
    Zhou G; Tian J; Tian Y; Ma Q; Li Q; Wang S; Shi H
    BMC Vet Res; 2023 Aug; 19(1):128. PubMed ID: 37598169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
    Wang Y; Xu F; Yuan C; Zhang Y; Ren J; Yue H; Ma T; Song Q
    Vaccine; 2024 Apr; 42(11):2848-2857. PubMed ID: 38514351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella enterica serovar Choleraesuis vector outperforms alum as an adjuvant, increasing a cross-protective immune response against Glaesserella parasuis.
    Li YA; Sun Y; Zhang Y; Wang X; Dieye Y; Wang S; Shi H
    Vet Microbiol; 2023 Dec; 287():109915. PubMed ID: 38000209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
    Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
    Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Immunization with Attenuated
    Zhou G; Tian Y; Tian J; Ma Q; Huang S; Li Q; Wang S; Shi H
    Microbiol Spectr; 2022 Dec; 10(6):e0236122. PubMed ID: 36377878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orf virus as an adjuvant enhances the immune response to a PCV2 subunit vaccine.
    Sun J; Ma J; Chen L; Xiao S; Xiao X; Fang L
    Vet Microbiol; 2024 Jun; 293():110088. PubMed ID: 38640639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Immunization with Attenuated
    Zhang G; Fu Y; Li Y; Li Q; Wang S; Shi H
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PCV3 Cap Virus-like Particle Vaccine with the Chimeric PCV2-Neutralizing Epitope Gene Is Effective in Mice.
    Wu X; Wang Q; Lu W; Wang Y; Han Z; Liang L; Gao S; Ma H; Luo X
    Vet Sci; 2024 Jun; 11(6):. PubMed ID: 38922011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both recombinant
    Zhang Y; Wu Y; Peng C; Li Z; Wang G; Wang H; Yu L; Wang F
    Heliyon; 2023 Dec; 9(12):e22941. PubMed ID: 38058449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Orf virus induced antibody production against capsid protein of porcine circovirus type 3 in mice.
    Gao K; Li H; Lei X; Sun Z; Zheng T; Chen M; Ning Z
    Vet Res Commun; 2023 Dec; 47(4):2071-2081. PubMed ID: 37421550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of plant-produced porcine circovirus-like particles in mice.
    Gunter CJ; Regnard GL; Rybicki EP; Hitzeroth II
    Plant Biotechnol J; 2019 Sep; 17(9):1751-1759. PubMed ID: 30791210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a simple and high-yielding fed-batch process for the production of porcine circovirus type 2 virus-like particle subunit vaccine.
    Cao W; Cao H; Yi X; Zhuang Y
    AMB Express; 2019 Oct; 9(1):164. PubMed ID: 31605297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live-Attenuated
    Lloren KKS; Lee JH
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C500 variants conveying complete mucosal immunity against fatal infections of pigs with
    Liu G; Li C; Liao S; Guo A; Wu B; Chen H
    Front Microbiol; 2023; 14():1210358. PubMed ID: 37779705
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative immunogenic and immunoprotective activities of PCV2d Cap and Rep antigens delivered by an efficient eukaryotic expression system engineered into a Salmonella vaccine vector.
    Lloren KKS; Sivasankar C; Lee JH
    Vet Microbiol; 2024 Jun; 295():110151. PubMed ID: 38870752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous Sequential Immunization Using Salmonella Oral Administration Followed by an Intranasal Boost with Ferritin-Based Nanoparticles Enhanced the Humoral Immune Response against H1N1 Influenza Virus.
    Wang Z; Zhang T; Jia F; Ge C; He Y; Tian Y; Wang W; Yang G; Huang H; Wang J; Shi C; Yang W; Cao X; Zeng Y; Wang N; Qian A; Wang C; Jiang Y
    Microbiol Spectr; 2023 Jun; 11(3):e0010223. PubMed ID: 37154735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice.
    Li YA; Sun Y; Zhang Y; Wang S; Shi H
    Vaccine; 2022 Aug; 40(33):4732-4741. PubMed ID: 35773121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.